Rapport Therapeutics, Inc. Common Stock (RAPP) 52-week high is $29.74
Rapport Therapeutics, Inc. Common Stock (RAPP) 52-week high is $29.74. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full RAPP research page for quote, filings, and the rest of the model. This satellite exists so “Rapport Therapeutics, Inc. Common Stock 52-week high” can rank with the actual number, then send you to /stock/rapp.